3rd Quarter - Report
NVG, LLC for PFIZER INC.
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; Graham-Cassidy amendment; Prescription drug coverage and payment policies; Medical innovation issues; H. 2430 FDA Reauthorization Act of 2017 - PDUFA; S. 934 FDA Reauthorization Act of 2017 - PDUFA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Budget/Appropriations BUD
Adverse drug events, immunotherapy and smoking cessation coverage issues in the FY 2018 LHHS Appropriations bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
| ANDREA LARUE | — |
Copyright/Patent/Trademark CPT
Intellectual property and potential changes to the patent system, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.